WallStreetZenWallStreetZen

NASDAQ: BJDX
Bluejay Diagnostics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Be the first to know when Wall Street analysts revise their BJDX stock forecasts and price targets.

Forecast return on equity

Is BJDX forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
35.72%

Forecast return on assets

Is BJDX forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

BJDX revenue forecast

What is BJDX's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$5.1M
Avg 2 year Forecast
$7.9M
Avg 3 year Forecast
$18.5M

BJDX vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
BJDX$0.55N/AN/A
TIVC$1.12N/AN/A
NUWE$0.28N/AN/A
BBLG$1.77N/AN/A
NAOV$0.75N/AN/A
View Top Medical Device Stocks

Bluejay Diagnostics Stock Forecast FAQ

What is BJDX's revenue growth forecast for 2025-2027?

(NASDAQ: BJDX) Bluejay Diagnostics's forecast annual revenue growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.33%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.27%.

Bluejay Diagnostics's revenue in 2024 is $0.On average, 1 Wall Street analysts forecast BJDX's revenue for 2025 to be $13,576,662, with the lowest BJDX revenue forecast at $13,576,662, and the highest BJDX revenue forecast at $13,576,662. On average, 1 Wall Street analysts forecast BJDX's revenue for 2026 to be $21,131,201, with the lowest BJDX revenue forecast at $21,131,201, and the highest BJDX revenue forecast at $21,131,201.

In 2027, BJDX is forecast to generate $49,682,519 in revenue, with the lowest revenue forecast at $49,682,519 and the highest revenue forecast at $49,682,519.

If you're new to stock investing, here's how to buy Bluejay Diagnostics stock.

What is BJDX's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: BJDX) forecast ROA is N/A, which is lower than the forecast US Medical Devices industry average of N/A.

What is BJDX's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: BJDX) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.